Wong C K M, Lai T, Holly J M P, Wheeler M H, Stewart C E H, Farndon J R
Department of Endocrine Surgery, Frenchay Hospital, Frenchay Park, Bristol, BS16 1LE, United Kingdom.
World J Surg. 2006 Mar;30(3):333-45. doi: 10.1007/s00268-005-0339-8.
In most cell types, influx of calcium (Ca2+) induces a growth or secretory response. The opposite occurs in parathyroid (PTH), cells where there is an inverse relationship between intracellular Ca2+ concentration and PTH secretion. We have examined the effects of calcium channel and metabolism modulators on insulin-like growth factors (IGFs) in a parathyroid cell culture model.
Cell cultures were prepared from 9 patients undergoing operation for hyperparathyroidism. Following adhesion, the cells were transferred to serum-free medium and dosed with IGF I, II +/- ethyleneglycol-bis(beta-aminoethyl)-N,N,N',N'-tetraacetic acid (EGTA), nifedipine, nickel, 2-aminoethoxy-diphenylborate (2-APB), or dantrolene. Proliferation (96 hours) was assessed by measuring tritiated thymidine incorporation and PTH release (1 and 3 hours) assayed by IRMA.
Both IGF I and II increased DNA synthesis to 162.8% +/- 10.6% (SEM) and 131.1% +/- 7.7%, respectively (P < 0.05). EGTA at 0.2 mmol (ionized Ca2+ 0.2 mmol) did not affect the response to both IGFs. EGTA at 2 mmol (ionized Ca2+ 0 mmol) reduced the DNA synthesis of IGF I and II to 29% and 26%, respectively (P < 0.05). Nifedipine and nickel (nonspecific Ca2+ channel blocker) were equally potent in negating the mitogenic effects of both IGFs. 2-APB (IP3R blocker) reduced the basal DNA synthesis to 51.3% +/- 8.4% but had no effect on either IGF. Dantrolene (ryanodine receptor blocker) negated IGF II induced mitogenisis (74.2% +/- 6.7%) and partially inhibited IGF I mitogenesis (123% +/- 6%) (P < 0.05). The rate of PTH secretion was greater after IGF II stimulation than after IGF I stimulation.
IGFs I and II induce mitogenesis by different calcium signaling pathways. These data suggest that parathyroid cells may utilize different calcium signaling pathways to distinguish growth factors and serum calcium changes.
在大多数细胞类型中,钙(Ca2+)内流会引发生长或分泌反应。而在甲状旁腺(PTH)细胞中情况则相反,细胞内Ca2+浓度与PTH分泌呈负相关。我们在甲状旁腺细胞培养模型中研究了钙通道和代谢调节剂对胰岛素样生长因子(IGF)的影响。
从9例接受甲状旁腺功能亢进手术的患者中制备细胞培养物。细胞贴壁后,转移至无血清培养基中,并给予IGF I、IGF II,同时添加或不添加乙二醇双(β-氨基乙基)-N,N,N',N'-四乙酸(EGTA)、硝苯地平、镍、2-氨基乙氧基二苯硼酸盐(2-APB)或丹曲林。通过测量氚标记胸腺嘧啶核苷掺入量评估增殖情况(96小时),通过免疫放射分析(IRMA)检测PTH释放(1小时和3小时)。
IGF I和IGF II均使DNA合成分别增加至162.8%±10.6%(标准误)和131.1%±7.7%(P<0.05)。0.2 mmol的EGTA(游离Ca2+ 0.2 mmol)不影响对两种IGF的反应。2 mmol的EGTA(游离Ca2+ 0 mmol)使IGF I和IGF II的DNA合成分别降至29%和26%(P<0.05)。硝苯地平和镍(非特异性Ca2+通道阻滞剂)在消除两种IGF的促有丝分裂作用方面同样有效。2-APB(肌醇三磷酸受体阻滞剂)使基础DNA合成降至51.3%±8.4%,但对两种IGF均无影响。丹曲林(兰尼碱受体阻滞剂)消除了IGF II诱导的有丝分裂(74.2%±6.7%),并部分抑制了IGF I的有丝分裂(123%±6%)(P<0.05)。IGF II刺激后的PTH分泌速率高于IGF I刺激后。
IGF I和IGF II通过不同的钙信号通路诱导有丝分裂。这些数据表明甲状旁腺细胞可能利用不同的钙信号通路来区分生长因子和血清钙变化。